In a study performed by Nakayama et al., CCNE1 expression was limited to 9 of 108 endometrial carcinomas, and CCNE1 overexpression was associated with reduced OS and RFS compared with an absence of CCNE1 amplification. Here, CCNE1 is linked to endometrial carcinoma.